Naphthoquinones as a Promising Class of Compounds for Facing the Challenge of Parkinson’s Disease

Naphthoquinones as a Promising Class of Compounds for Facing the Challenge of Parkinson’s Disease

Parkinson’s disease (PD) is a degenerative disease that affects approximately 6.1 million people and is primarily caused by the loss of dopaminergic neurons. Naphthoquinones have several biological activities explored in the literature, including neuroprotective effects. Therefore, this review shows...

Full description

Bibliographic Details
Main Authors: Thaís Barreto Santos, Leonardo Gomes Cavalieri de Moraes, Paulo Anastácio Furtado Pacheco, Douglas Galdino dos Santos, Rafaella Machado de Assis Cabral Ribeiro, Caroline dos Santos Moreira, David Rodrigues da Rocha
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Pharmaceuticals
Subjects:
naphthoquinones
Parkinson disease
P2X7 receptor
Online Access:https://www.mdpi.com/1424-8247/16/11/1577

Internet

https://www.mdpi.com/1424-8247/16/11/1577

Similar Items